Fintel reports that on November 22, 2024, B. Riley Securities initiated coverage of Viking Therapeutics (LSE:0VQA) with a Buy recommendation.
https://www.nasdaq.com/articles/b-riley-securities-initiates-coverage-viking-therapeutics-lse-0vqa-buy-recommendation